ELAHERE conc perf 100 mg/20ml
AbbVie AG
Prodotti simili
| Prodotto | Articoli | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
IMDYLLTRA subst sèche 10 mg (ec 07/26) Tarlatamab | flacon 1 pz | 1186174 | - | Cat. A | - | |
IMDYLLTRA subst sèche 1 mg (ec 07/26) Tarlatamab | flacon 1 pz | 1186173 | - | Cat. A | - | |
VYLOY subst sèche 300 mg (ec 05/26) Zolbetuximab | flacon 1 pz | 1186527 | - | Cat. A | - | |
TEPKINLY sol inj 4 mg/0.8ml (ec 03/26) Epcoritamab | flacon 0.8 ml | 1169037 | CHF 565.10 | Cat. A | SL / 10% | |
RYBREVANT SC sol inj 2240 mg/14ml (ec 02/26) Amivantamab | flacon 14 ml | 1154816 | CHF 5146.85 | Cat. A | SL / 10% | |
RYBREVANT SC sol inj 1600 mg/10ml (ec 02/26) Amivantamab | flacon 10 ml | 1154815 | CHF 3864.25 | Cat. A | SL / 10% | |
DATROWAY subst sèche 100 mg Datopotamab deruxtecan | flacon 1 pz | 1140751 | - | Cat. A | - | |
BLENREP subst sèche 100 mg Belantamab mafodotin | flacon 1 pz | 1138132 | - | Cat. A | - | |
BLENREP subst sèche 70 mg Belantamab mafodotin | flacon 1 pz | 1138131 | - | Cat. A | - | |
VYLOY subst sèche 100 mg Zolbetuximab | flacon 1 pz flacon 3 pz | 1136827 1136828 | - - | Cat. A Cat. A | - - | |
QARZIBA conc perf 20.25 mg/4.5ml Dinutuximab beta | flacon 4.5 ml | 1115455 | CHF 8602.80 | Cat. A | SL / 10% | |
TEPKINLY sol inj 48 mg/0.8ml Epcoritamab | flacon 0.8 ml flacon 1 pz | 1152109 1050873 | CHF 6588.85 CHF 6588.85 | Cat. A Cat. A | SL / 10% SL / 10% | |
ELREXFIO sol inj 76 mg/1.9ml Elranatamab | flacon 1.9 ml | 1036402 | CHF 5374.50 | Cat. A | SL / 10% | |
COLUMVI conc perf 10 mg/10ml Glofitamab | flacon 10 ml | 1048428 | - | Cat. A | - | |
COLUMVI conc perf 2.5 mg/2.5ml Glofitamab | flacon 2.5 ml | 1048427 | - | Cat. A | - | |
IMJUDO conc perf 300 mg/15ml Tremelimumab | vial 15 ml | 1044525 | CHF 17670.65 | Cat. A | SL / 10% | |
IMJUDO conc perf 25 mg/1.25ml Tremelimumab | vial 1.25 ml | 1044524 | CHF 1550.15 | Cat. A | SL / 10% | |
TALVEY sol inj 3 mg/1.5ml Talquetamab | flacon 1.5 ml | 1042202 | CHF 362.90 | Cat. A | SL / 10% | |
TALVEY sol inj 40 mg/ml Talquetamab | flacon 1 ml | 1042203 | CHF 4636.10 | Cat. A | SL / 10% | |
ELREXFIO sol inj 44 mg/1.1ml Elranatamab | flacon 1.1 ml | 1036401 | CHF 3125.80 | Cat. A | SL / 10% | |
LUNSUMIO conc perf 30 mg/30ml Mosunetuzumab | flacon 30 ml | 1019998 | - | Cat. A | - | |
LUNSUMIO conc perf 1 mg/ml Mosunetuzumab | flacon 1 ml | 1019997 | - | Cat. A | - | |
TECVAYLI sol inj 153 mg/1.7ml Teclistamab | flacon 1.7 ml | 1004352 | CHF 4285.55 | Cat. A | SL / 10% | |
TECVAYLI sol inj 30 mg/3ml Teclistamab | flacon 3 ml | 1004263 | CHF 853.50 | Cat. A | SL / 10% | |
MINJUVI subst sèche 200 mg Tafasitamab | flacon 1 pz | 1000928 | CHF 754.15 | Cat. A | SL / 10% | |
RYBREVANT conc perf 350 mg/7ml Amivantamab | flacon 1 pz | 7823403 | CHF 1299.00 | Cat. A | SL / 10% | |
POTELIGEO conc perf 4 mg/ml Mogamulizumab | flacon 1 pz | 7819792 | CHF 1433.15 | Cat. A | SL / 10% | |
PADCEV subst sèche 20 mg Enfortumab vedotin | flacon 1 pz | 7818693 | - | Cat. A | - | |
PADCEV subst sèche 30 mg Enfortumab vedotin | flacon 1 pz | 7818694 | - | Cat. A | - | |
TRODELVY subst sèche 180 mg Sacituzumab govitecan | flacon 1 pz | 7813520 | CHF 1021.60 | Cat. A | SL / 10% | |
POLIVY subst sèche 140 mg i.v. Polatuzumab vedotin | flacon 1 pz | 7805113 | CHF 9762.80 | Cat. A | SL / 10% | |
POLIVY subst sèche 30 mg i.v. Polatuzumab vedotin | flacon 1 pz | 7805112 | CHF 2164.05 | Cat. A | SL / 10% | |
MYLOTARG subst sèche 5 mg Gemtuzumab ozogamicine | flacon 1 pz | 7768973 | - | Cat. A | - | |
EMPLICITI subst sèche 400 mg Elotuzumab | flacon 1 pz | 6696244 | CHF 1470.20 | Cat. A | SL / 10% | |
EMPLICITI subst sèche 300 mg Elotuzumab | flacon 1 pz | 6696238 | CHF 1106.75 | Cat. A | SL / 10% | |
BLINCYTO subst sèche 38.5 mcg Blinatumomab | flacon 1 pz | 6605796 | CHF 2428.95 | Cat. A | SL / 10% | |
ADCETRIS subst sèche 50 mg Brentuximab vedotin | flacon 1 pz flacon 2 pz | 5574740 6059891 | CHF 3263.75 CHF 6434.85 | Cat. A Cat. A | SL / 10% SL / 10% | |
YERVOY conc perf 50 mg/10ml Ipilimumab | flacon 1 pz | 5045390 | CHF 3499.45 | Cat. A | SL / 10% | |
YERVOY conc perf 200 mg/40ml Ipilimumab | flacon 1 pz | 5045409 | CHF 13451.25 | Cat. A | SL / 10% |